BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 34036855)

  • 1. Unravelling Pathophysiology of Neurological and Psychiatric Complications of COVID-19 Using Brain Organoids.
    Ng JH; Sun A; Je HS; Tan EK
    Neuroscientist; 2023 Feb; 29(1):30-40. PubMed ID: 34036855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium.
    Jacob F; Pather SR; Huang WK; Zhang F; Wong SZH; Zhou H; Cubitt B; Fan W; Chen CZ; Xu M; Pradhan M; Zhang DY; Zheng W; Bang AG; Song H; Carlos de la Torre J; Ming GL
    Cell Stem Cell; 2020 Dec; 27(6):937-950.e9. PubMed ID: 33010822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human brain organoids to explore SARS-CoV-2-induced effects on the central nervous system.
    Ostermann PN; Schaal H
    Rev Med Virol; 2023 Mar; 33(2):e2430. PubMed ID: 36790825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 targets glial cells in human cortical organoids.
    McMahon CL; Staples H; Gazi M; Carrion R; Hsieh J
    Stem Cell Reports; 2021 May; 16(5):1156-1164. PubMed ID: 33979600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 research using human pluripotent stem cells and organoids.
    Deguchi S; Serrano-Aroca Á; Tambuwala MM; Uhal BD; Brufsky AM; Takayama K
    Stem Cells Transl Med; 2021 Nov; 10(11):1491-1499. PubMed ID: 34302450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons.
    Kong W; Montano M; Corley MJ; Helmy E; Kobayashi H; Kinisu M; Suryawanshi R; Luo X; Royer LA; Roan NR; Ott M; Ndhlovu LC; Greene WC
    mBio; 2022 Dec; 13(6):e0230822. PubMed ID: 36314791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
    Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
    Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the neurological implications of acute and long COVID using brain organoids.
    García-González L; Martí-Sarrias A; Puertas MC; Bayón-Gil Á; Resa-Infante P; Martinez-Picado J; Navarro A; Acosta S
    Dis Model Mech; 2023 Jul; 16(7):. PubMed ID: 37458167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
    Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
    mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Human Nose Organoid Respiratory Virus Model: an
    Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
    mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell-derived organoid models for SARS-CoV-2 and its molecular interaction with host cells.
    Dawoody Nejad L; Julian LM
    Mol Biol Rep; 2023 Dec; 50(12):10627-10635. PubMed ID: 37740859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.
    Chiu MC; Li C; Liu X; Song W; Wan Z; Yu Y; Huang J; Xiao D; Chu H; Cai JP; To KK; Yuen KY; Zhou J
    mBio; 2022 Aug; 13(4):e0194422. PubMed ID: 35938726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids.
    Trevisan M; Riccetti S; Sinigaglia A; Barzon L
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human organoid models to study SARS-CoV-2 infection.
    Han Y; Yang L; Lacko LA; Chen S
    Nat Methods; 2022 Apr; 19(4):418-428. PubMed ID: 35396481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.
    Wang C; Zhang M; Garcia G; Tian E; Cui Q; Chen X; Sun G; Wang J; Arumugaswami V; Shi Y
    Cell Stem Cell; 2021 Feb; 28(2):331-342.e5. PubMed ID: 33450186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotropic Effects of SARS-CoV-2 Modeled by the Human Brain Organoids.
    Ramani A; Pranty AI; Gopalakrishnan J
    Stem Cell Reports; 2021 Mar; 16(3):373-384. PubMed ID: 33631123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Organoids as a Promising Platform for Fighting COVID-19.
    Chen D; Su X; Chen H; Chen S; Zhao Y; Wei W
    Int J Biol Sci; 2022; 18(3):901-910. PubMed ID: 35173525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.
    Stefano GB; Büttiker P; Weissenberger S; Ptacek R; Wang F; Esch T; Bilfinger TV; Raboch J; Kream RM
    Curr Neuropharmacol; 2022; 20(6):1229-1240. PubMed ID: 34951387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
    Bauer L; van Riel D
    mBio; 2023 Feb; 14(1):e0292022. PubMed ID: 36651750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iPSCs-Derived Platform: A Feasible Tool for Probing the Neurotropism of SARS-CoV-2.
    Mao XY; Jin WL
    ACS Chem Neurosci; 2020 Sep; 11(17):2489-2491. PubMed ID: 32840109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.